Nav: Home

Cancer registries in resource-constrained countries can inform policy to reduce cancer burden

December 15, 2016

Oxford, December 15, 2016 - Data from population-based cancer registries are vital for informing health programs, policies and strategies for cancer screening and treatment. A special issue of Cancer Epidemiology, prepared under the auspices of the Centers for Disease Control and Prevention, offers lessons for planning and supporting cancer registration in resource-constrained settings to support data-driven policies on cancer prevention, early detection and appropriate treatment leading to significant cost savings for government and society as a whole.

The Guest Editors of the special issue, Dr. Florence Tangka and Dr. Mona Saraiya of the Centers for Disease Control and Prevention, and Dr. Sujha Subramanian and Dr. Patrick Edwards of RTI International (contractor), note that there are substantial differences in the existence, geographical coverage and quality of cancer registration across the world. Dr. Tangka commented: "There is almost 100% coverage in North America, but less than 10% in Central and South America, Asia and Africa. These countries are essentially fighting cancer blindfolded as they often can't know how to best direct their resources."

Dr. Subramanian added: "The articles in the special issue show that lack of continuous and sustained support for surveillance infrastructure can disrupt data collection and lead to the inefficient use of resources. Although cancer registries incur substantial set-up costs, once established the cost per case is low and countries then benefit from economies of scale. This special issue of Cancer Epidemiology establishes baseline information to identify efficiencies in data collection, which is consistently reported as a high cost for registries. We hope that these findings will encourage other countries to establish registries."

The special issue reviews cancer registries in Kenya, Uganda, Colombia, India (Mumbai), and Barbados. and offers lessons for other countries with similar resource constraints.
-end-
Notes for editors

The special issue, Cost of Cancer Registration, is published in Cancer Epidemiology, volume 45, Supplement 1 (December 2016), published by Elsevier.

Studies included in this issue are available to credentialed journalists upon request; please contact Elsevier's Newsroom at newsroom@elsevier.com or +31 20 485 2492.

About Cancer Epidemiology

Cancer Epidemiology: the international journal for cancer epidemiology, detection and prevention is dedicated to increasing understanding about cancer causes, prevention and control. The scope of the journal embraces all aspects of cancer epidemiology including: descriptive epidemiology and statistics; studies of risk factors for disease initiation, development and prognosis; screening, early detection and accurate diagnosis; prevention and evaluation of interventions; and methodological issues and theory.

About Elsevier

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions -- among them ScienceDirect, Scopus, Research Intelligence and ClinicalKey -- and publishes over 2,500 journals, including The Lancet and Cell, and more than 35,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group, a world-leading provider of information and analytics for professional and business customers across industries. http://www.elsevier.com

Media contact

Sarah Jenkins
Elsevier
+44 1865 843243
sl.jenkins@elsevier.com

Elsevier

Related Cancer Screening Articles:

Screening for thyroid cancer not recommended
The US Preventive Services Task Force recommends against screening for thyroid cancer in adults without any signs or symptoms.
New method for early screening of colorectal cancer
A highly sensitive method that can detect even the earlier stages of colorectal cancer has been developed by researchers in Japan.
Free lung-cancer screening in the Augusta area finds more than double the cancer rate of previous screenings
The first year of free lung cancer screening in the Augusta, Ga., area found more than double the rate seen in a previous large, national study as well as a Massachusetts-based screening for this No.
Breast cancer screening associated with substantial overdiagnosis
Breast cancer screening in Denmark was associated with a substantial increase in the incidence of nonadvanced tumors and DCIS but not with a reduction in the incidence of advanced tumors.
Cervical cancer screening could be less frequent, start later
Women may only need cervical cancer screening every 5-10 years -- instead of every three years, as currently recommended -- and may be able to start the screenings later in life, according to Harvard T.H.
How breast cancer screening could be better and less painful
The breast cancer screening tests offered to women may in many cases be unnecessarily painful.
Improving participation in cancer screening should be a priority
Early diagnosis of cancer is linked to better survival rates.
Early detection, smaller cancer among benefits of skin cancer screening at PCP visits
Skin cancer screenings performed by primary care physicians (PCPs) during routine office visits improve the detection of potentially deadly melanomas and find them in earlier stages, according to new research from the University of Pittsburgh School of Medicine.
Lung cancer screening: New Canadian guideline
Adults aged 55-74 years who are at high risk of lung cancer -- current or former smokers (i.e., have quit within the past 15 years) with at least a 30 pack-year history or more -- should be screened annually up to three times using low-dose computed tomography (CT), according to a new guideline from the Canadian Task Force on Preventive Health Care published in Canadian Medical Association Journal.
Study: Eliminating cost for colorectal cancer screening doesn't improve screening rates
Making colonoscopy available at no cost to eligible Medicare beneficiaries under the Affordable Care Act (ACA) did not increase the number of people in this target population who regularly undergo the procedure, says a new large scale national study from University Hospitals Case Medical Center Seidman Cancer Center.

Related Cancer Screening Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#529 Do You Really Want to Find Out Who's Your Daddy?
At least some of you by now have probably spit into a tube and mailed it off to find out who your closest relatives are, where you might be from, and what terrible diseases might await you. But what exactly did you find out? And what did you give away? In this live panel at Awesome Con we bring in science writer Tina Saey to talk about all her DNA testing, and bioethicist Debra Mathews, to determine whether Tina should have done it at all. Related links: What FamilyTreeDNA sharing genetic data with police means for you Crime solvers embraced...